Author

Vedita Anand Singh

Indian Institute of Technology RoorkeeORCID 0000-0003-0490-232XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Adolfo García‐SastreiD· 1 shared Ayush Mehta· 1 shared Chandra Shekhar KumariD· 1 shared Dylan J. MendonsaiD· 1 shared Emi R. Matsuo· 1 shared Gaurav Kumar SharmaiD· 1 shared Jihaan Adonis· 1 shared Jonathan A. Covel· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adolfo García‐SastreORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Small molecule inhibition of the mitochondrial lipid transfer protein STARD7 attenuates influenza viral replication

Shipra Sharma, Oyahida Khatun, Jihaan Adonis, Shaochen You, Kevin Hartenbower, Vedita Anand Singh, Namir Shaabani, Saikat De, Emi R. Matsuo, Rachel Y. Sattler, Jonathan A. Covel, Kris M. White, Laura Martin‐Sancho, Malina A. Bakowski, Dylan J. Mendonsa, , Sumit K. Chanda

This paper identifies a small molecule, M4, that inhibits influenza A and B replication by targeting the host protein STARD7, preventing vRNP nuclear export and demonstrating synergistic antiviral effects with baloxavir in mice.

PLoS Pathogens · Sep 11, 2026Peer-reviewedMicrobiology

Chimeric chikungunya virus-like particles with surface exposed SARS-CoV-2 RBD elicits potent immunogenic responses in mice.

Vedita Anand Singh, Sanketkumar Nehul, Chandra Shekhar Kumar, Manidipa Banerjee, Pravindra Kumar, Gaurav Kumar Sharma, Shailly Tomar

This study develops a bivalent chimeric virus-like particle vaccine displaying CHIKV and SARS-CoV-2 RBD antigens, showing potent immunogenicity in mice.

bioRxiv · Jan 29, 2023 · PreprintMolecular Biology